| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Bios Equity Cof, LP is a Director, 10% Owner at ACTUATE THERAPEUTICS, INC.. Recent SEC Form 4 filings include 3 buys and 3 sells.
Estimated insider holdings value: $599K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | - | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | +56.5% | -1.4% | -10.2% | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -1.7% | -1.4% | -10.2% |